$SHC
Sotera Health Co Stock $shc

$shc Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000182247922000030 Filed on May 05, 2022

Income Statement

Concept	2022 Q1	2021 Q4	2021 Q1
Revenue	$236.8M	$241.2M	$212.1M
YoY Change	11.6%	11.28%	12.72%
Cost Of Revenue	$107.9M	$107.3M	$96.78M
YoY Change	11.47%	11.42%	5.56%
Gross Profit	$128.9M	$134.0M	$115.4M
YoY Change	11.7%	11.07%	19.54%
Gross Profit Margin	54.43%	55.52%	54.38%
Selling, General & Admin	$59.54M	$51.83M	$52.47M
YoY Change	13.49%	-2.58%	41.59%
% of Gross Profit	46.2%	38.69%	45.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$15.87M	$38.15M	$15.38M
YoY Change	3.17%	4.51%	-4.54%
% of Gross Profit	12.31%	28.48%	13.33%
Operating Expenses	$75.38M	$67.53M	$69.01M
YoY Change	9.24%	-0.84%	33.6%
Operating Profit	$53.49M	$66.43M	$46.36M
YoY Change	15.37%	26.53%	3.34%
Interest Expense	-$10.40M	-$15.54M	-$21.28M
YoY Change	-51.11%	-67.82%	-62.37%
% of Operating Profit	-19.45%	-23.4%	-45.9%
Other Income/Expense, Net	$2.967M	$7.854M	$3.890M
YoY Change	-23.73%	54.0%	-223.49%
Pretax Income	$45.27M	$58.73M	$14.08M
YoY Change	221.45%	-267.33%	-199.03%
Income Tax	$14.63M	$22.74M	$3.017M
% Of Pretax Income	32.31%	38.71%	21.42%
Net Earnings	$30.64M	$36.00M	$10.84M
YoY Change	182.61%	-182.37%	-652.04%
Net Earnings / Revenue	12.94%	14.92%	5.11%
Basic Earnings Per Share	$0.11		$0.04
Diluted Earnings Per Share	$0.11	$128.7K	$0.04
COMMON SHARES
Basic Shares Outstanding	279.8M shares	282.9M shares	278.8M shares
Diluted Shares Outstanding	279.9M shares		279.0M shares

Balance Sheet

Concept	2022 Q1	2021 Q4	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$121.4M	$106.9M	$108.0M
YoY Change	12.44%	4.41%
Cash & Equivalents	$121.4M	$106.9M	$108.0M
Short-Term Investments
Other Short-Term Assets	$16.36M	$7.311M	$11.76M
YoY Change	39.06%	-8.84%
Inventory	$45.70M	$54.29M	$33.38M
Prepaid Expenses
Receivables	$114.8M	$108.2M	$96.39M
Other Receivables	$11.00M	$7.155M	$22.20M
Total Short-Term Assets	$371.6M	$346.0M	$328.4M
YoY Change	13.15%	9.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$669.2M	$650.8M	$611.6M
YoY Change	9.41%	6.72%
Goodwill	$1.126B	$1.120B	$1.107B
YoY Change	1.73%	0.39%
Intangibles	$582.1M	$598.8M	$656.6M
YoY Change	-11.34%	-6.92%
Long-Term Investments	$9.550M	$9.405M	$9.227M
YoY Change	3.5%	-30.11%
Other Assets	$27.49M	$12.87M	$9.281M
YoY Change	196.17%	38.28%
Total Long-Term Assets	$2.464B	$2.444B	$2.449B
YoY Change	0.64%	-0.11%
TOTAL ASSETS
Total Short-Term Assets	$371.6M	$346.0M	$328.4M
Total Long-Term Assets	$2.464B	$2.444B	$2.449B
Total Assets	$2.836B	$2.790B	$2.777B
YoY Change	2.12%	1.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$55.22M	$72.87M	$57.17M
YoY Change	-3.42%	39.06%
Accrued Expenses	$60.46M	$61.86M	$56.37M
YoY Change	7.25%	2.22%	-6.85%
Deferred Revenue	$12.90M	$8.700M	$6.000M
YoY Change	115.0%	42.62%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.342M	$1.160M	$1.100M
YoY Change	22.0%
Total Short-Term Liabilities	$143.9M	$161.2M	$138.0M
YoY Change	4.23%	14.63%
LONG-TERM LIABILITIES
Long-Term Debt	$1.745B	$1.744B	$1.838B
YoY Change	-5.06%	-4.45%
Other Long-Term Liabilities	$16.19M	$16.27M	$18.80M
YoY Change	-13.87%	-7.04%
Total Long-Term Liabilities	$1.761B	$1.760B	$1.856B
YoY Change	-5.15%	-4.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$143.9M	$161.2M	$138.0M
Total Long-Term Liabilities	$1.761B	$1.760B	$1.856B
Total Liabilities	$2.194B	$2.203B	$2.311B
YoY Change	-5.09%	-4.48%
SHAREHOLDERS EQUITY
Retained Earnings	-$441.6M	-$472.2M	-$578.3M
YoY Change	-23.64%	-19.84%
Common Stock	$2.860M	$2.860M	$2.860M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$33.54M	$33.55M	$34.00M
YoY Change	-1.36%	-1.34%
Treasury Stock Shares	3.107M shares	3.052M shares	3.090M shares
Shareholders Equity	$642.1M	$586.1M	$463.3M
YoY Change
Total Liabilities & Shareholders Equity	$2.836B	$2.790B	$2.777B
YoY Change	2.12%	1.02%

Cashflow Statement

Concept	2022 Q1	2021 Q4	2021 Q1
OPERATING ACTIVITIES
Net Income	$30.64M	$36.00M	$10.84M
YoY Change	182.61%	-182.37%	-652.04%
Depreciation, Depletion And Amortization	$15.87M	$38.15M	$15.38M
YoY Change	3.17%	4.51%	-4.54%
Cash From Operating Activities	$49.97M	$66.35M	$56.16M
YoY Change	-11.03%	202.97%	886.98%
INVESTING ACTIVITIES
Capital Expenditures	$35.55M	-$41.26M	$20.94M
YoY Change	69.74%	107.36%	61.23%
Acquisitions	$0.00		$13.15M
YoY Change	-100.0%
Other Investing Activities	$63.00K	-$31.00M	-$25.60M
YoY Change	-100.25%	-2918.09%
Cash From Investing Activities	-$35.48M	-$72.26M	-$46.52M
YoY Change	-23.72%	284.38%	258.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$0.00		$0.00
YoY Change			-100.0%
Cash From Financing Activities	-$449.0K	-1.782M	-$3.783M
YoY Change	-88.13%	-83.19%	-107.67%
NET CHANGE
Cash From Operating Activities	$49.97M	66.35M	$56.16M
Cash From Investing Activities	-$35.48M	-72.26M	-$46.52M
Cash From Financing Activities	-$449.0K	-1.782M	-$3.783M
Net Change In Cash	$14.52M	-7.694M	$5.562M
YoY Change	161.09%	2.59%	-86.81%
FREE CASH FLOW
Cash From Operating Activities	$49.97M	$66.35M	$56.16M
Capital Expenditures	$35.55M	-$41.26M	$20.94M
Free Cash Flow	$14.42M	$107.6M	$35.22M
YoY Change	-59.05%	157.45%	-582.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001822479
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-39729
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	SOTERA HEALTH COMPANY
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3531161
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	9100 South Hills Blvd
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Broadview Heights
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	44147
CY2022Q1	dei	City Area Code CityAreaCode	440
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	262-1410
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
CY2022Q1	dei	Trading Symbol TradingSymbol	SHC
CY2021Q4	us-gaap	Inventory Net InventoryNet	54288000	USD
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	282817234	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	121440000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	106917000	USD
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	6000	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	7000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1458000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1287000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	114763000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	108183000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	45701000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5885000	USD
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	9550000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	83956000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	71923000	USD
CY2022Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	5694000	USD
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	4643000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	371560000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	345961000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	669161000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	650797000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	36984000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	39946000	USD
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5769000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	9405000	USD
CY2022Q1	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	7285000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	5478000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	27488000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12866000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	582144000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	598844000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	1125828000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	1120320000	USD
CY2022Q1	us-gaap	Assets Assets	2835769000	USD
CY2021Q4	us-gaap	Assets Assets	2789502000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	55221000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	72868000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60459000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	61861000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	12928000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8669000	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1342000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1160000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	8906000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9289000	USD
CY2022Q1	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	627000	USD
CY2021Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	619000	USD
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4368000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6695000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	143851000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	161161000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1744541000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1743534000	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	40014000	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	40877000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31065000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	33017000	USD
CY2022Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	42995000	USD
CY2021Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	41833000	USD
CY2022Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	20916000	USD
CY2021Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	20745000	USD
CY2022Q1	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	11608000	USD
CY2021Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	11464000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16188000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16274000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	142461000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	134501000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	2193639000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	2203406000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1200000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	286037000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	286037000	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	2860000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2860000	USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	120000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	120000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	3107000	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	3052000	shares
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	33536000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	212148000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	33545000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1177097000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1172593000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-441605000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-472246000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-62686000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-83566000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	642130000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	586096000	USD
CY2022Q1	us-gaap	Minority Interest MinorityInterest	0	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	0	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	642130000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	586096000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2835769000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2789502000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	236754000	USD
CY2021Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-21282000	USD
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	107879000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	96776000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	128875000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	115372000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	59542000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	52465000	USD
CY2022Q1	shc	Amortization Of Intangible Assets Nonproduction AmortizationOfIntangibleAssetsNonproduction	15841000	USD
CY2021Q1	shc	Amortization Of Intangible Assets Nonproduction AmortizationOfIntangibleAssetsNonproduction	16543000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	75383000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	69008000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	53492000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	46364000	USD
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-10404000	USD
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-14312000	USD
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-788000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-578000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2967000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3890000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	45267000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	14082000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14626000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3017000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	30641000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	11065000	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	223000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	30641000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	10842000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	92000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	84000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	7730000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7522000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	274000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	249000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	2109000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	0	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	6179000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	0	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	14975000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3086000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	51521000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	208000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	51521000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	279829000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	278827000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	279908000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	278968000	shares
CY2022Q1	us-gaap	Profit Loss ProfitLoss	30641000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	11065000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	15867000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	15379000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20182000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	22282000	USD
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-14312000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5633000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3637000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4538000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3449000	USD
CY2022Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	520000	USD
CY2021Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	551000	USD
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-2430000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-2354000	USD
CY2022Q1	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	7364000	USD
CY2021Q1	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	853000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1414000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1663000	USD
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1989000	USD
CY2021Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2843000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6387000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4134000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9323000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1099000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	8934000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	2324000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-12742000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	6625000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2479000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5542000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-5222000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-4518000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-81000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1513000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	341000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	282000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	49967000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	56159000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35546000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20942000	USD
CY2021Q1	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	12425000	USD
CY2022Q1	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3783000	USD
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	487000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-295000	USD
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	13152000	USD
CY2022Q1	shc	Payments To Acquire Businesses Net Of Cash Acquired Adjustments PaymentsToAcquireBusinessesNetOfCashAcquiredAdjustments	-63000	USD
CY2021Q1	shc	Payments To Acquire Businesses Net Of Cash Acquired Adjustments PaymentsToAcquireBusinessesNetOfCashAcquiredAdjustments	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35483000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-46519000	USD
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	31000	USD
CY2021Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3435000	USD
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-418000	USD
CY2021Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-348000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-449000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14522000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5562000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	106924000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	102454000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	121446000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	108016000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	15809000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	19745000	USD
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	13505000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	11561000	USD
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	9508000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	7389000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	454574000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3440000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	249000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3086000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	0	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	11065000	USD
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	12618000	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8979000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	465744000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	586096000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4513000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	274000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	14975000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	6179000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	30641000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	642130000	USD
CY2022Q1	us-gaap	Basis Of Accounting BasisOfAccounting	Basis of Presentation<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Sotera Health Company (also referred to herein as the “Company,” “we,” “our,” “us” or “its”), is a global provider of mission-critical sterilization and lab testing and advisory services to the medical device and pharmaceutical industries with operations primarily in the Americas, Europe and Asia. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate and report in three segments, Sterigenics, Nordion and Nelson Labs. We describe our reportable segments in Note 18, “Segment Information”. All significant intercompany balances and transactions have been eliminated in consolidation. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represented the noncontrolling stockholders’ proportionate share of the total equity in the Company’s consolidated subsidiaries. In the second quarter of 2021, we purchased the outstanding noncontrolling interests of 15% and 33% in our two China subsidiaries. Refer to Note 4, “Acquisitions”</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional details. Prior to our acquisition of the noncontrolling interests in our two subsidiaries in China, we consolidated the results of operations of these subsidiaries with our results of operations and reflected the noncontrolling interests on our Consolidated Statements of Operations and Comprehensive Income as “Net income attributable to noncontrolling interests.”</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2021, we purchased the 15% noncontrolling interest that remained from the August 2018 acquisition of Nelson Laboratories Fairfield, Inc. (“Nelson Labs Fairfield”). As the purchase of this noncontrolling interest was mandatorily redeemable, no earnings were allocated to this noncontrolling interest. See Note 4, “Acquisitions”</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional details.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we acquired a 60% equity ownership interest in a joint venture to construct an E-beam facility in Alberta, Canada in connection with our acquisition of Iotron Industries Canada, Inc. (“Iotron”). We have determined this to be an investment in a variable interest entity (“VIE”). The investment is not consolidated as the Company has concluded that we are not the primary beneficiary of the VIE. The Company accounts for the joint venture using the equity method. The investment is reflected within “Investment in unconsolidated affiliates” on the Consolidated Balance Sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – In preparing our consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”), we make estimates and assumptions that affect the amounts reported and the accompanying notes. We regularly evaluate the estimates and assumptions used and revise them as new information becomes available. Actual results may vary from those estimates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interim Financial Statements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">– The accompanying consolidated financial statements include the assets, liabilities, operating results, and cash flows of the Company and its wholly owned subsidiaries. These financial statements are prepared in accordance with U.S. GAAP for interim financial information and the instructions to the Quarterly Report on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. These unaudited interim financial statements should be read in conjunction with the Company's annual consolidated financial statements and accompanying notes on Form 10-K for the year ended December 31, 2021.</span></div>
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates – In preparing our consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”), we make estimates and assumptions that affect the amounts reported and the accompanying notes. We regularly evaluate the estimates and assumptions used and revise them as new information becomes available. Actual results may vary from those estimates.
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	124000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	45701000	USD
CY2022Q1	us-gaap	Inventory Gross InventoryGross	45827000	USD
CY2021Q4	us-gaap	Inventory Gross InventoryGross	54412000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	236754000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	212148000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	18500000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	15600000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	12900000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8700000	USD
	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	2800000	USD
CY2022Q1	us-gaap	Inventory Adjustments InventoryAdjustments	126000	USD
CY2022Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	32451000	USD
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	41514000	USD
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	758000	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	3919000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	54288000	USD
CY2022Q1	us-gaap	Prepaid Taxes PrepaidTaxes	26752000	USD
CY2021Q4	us-gaap	Prepaid Taxes PrepaidTaxes	24937000	USD
CY2022Q1	us-gaap	Prepaid Insurance PrepaidInsurance	8107000	USD
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	10707000	USD
CY2022Q1	us-gaap	Prepaid Rent PrepaidRent	1203000	USD
CY2021Q4	us-gaap	Prepaid Rent PrepaidRent	920000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	18547000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	15565000	USD
CY2022Q1	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	3805000	USD
CY2021Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	3144000	USD
CY2022Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	493000	USD
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	623000	USD
CY2022Q1	shc	Prepaid Maintenance Contracts Current PrepaidMaintenanceContractsCurrent	336000	USD
CY2021Q4	shc	Prepaid Maintenance Contracts Current PrepaidMaintenanceContractsCurrent	279000	USD
CY2022Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	1500000	USD
CY2021Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	2512000	USD
CY2022Q1	shc	Prepaid Software Licensing Current PrepaidSoftwareLicensingCurrent	1428000	USD
CY2021Q4	shc	Prepaid Software Licensing Current PrepaidSoftwareLicensingCurrent	2055000	USD
CY2022Q1	us-gaap	Supplies Supplies	3587000	USD
CY2021Q4	us-gaap	Supplies Supplies	3374000	USD
CY2022Q1	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Asset EmbeddedDerivativeFairValueOfEmbeddedDerivativeAsset	1842000	USD
CY2021Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Asset EmbeddedDerivativeFairValueOfEmbeddedDerivativeAsset	496000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	16356000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	7311000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	83956000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	71923000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	1120320000	USD
CY2022Q1	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	56000	USD
CY2022Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	5452000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	1125828000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1018831000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	545844000	USD
CY2022Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	109157000	USD
CY2022Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1127988000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	545844000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1015408000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	524507000	USD
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	107943000	USD
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1123351000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	524507000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	62157000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	82016000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	81237000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	43437000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	23181000	USD
CY2022Q1	shc	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	180959000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	472987000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P9Y6M
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	29391000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	33334000	USD
CY2022Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	3134000	USD
CY2021Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	3259000	USD
CY2022Q1	shc	Accrued Interest Expense Current AccruedInterestExpenseCurrent	10132000	USD
CY2021Q4	shc	Accrued Interest Expense Current AccruedInterestExpenseCurrent	10755000	USD
CY2022Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	308000	USD
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	7708000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4314000	USD
CY2022Q1	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	1833000	USD
CY2021Q4	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	1797000	USD
CY2022Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	1407000	USD
CY2021Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	2068000	USD
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	2333000	USD
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2209000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4213000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4125000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60459000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	61861000	USD
CY2022Q1	shc	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	0	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	1763550000	USD
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1763550000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1763550000	USD
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	19009000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	20016000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1744541000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1743534000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	450000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1763100000	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.323
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.214
CY2022Q1	shc	Defined Benefit Plan Annual Funding Requirements For Next Five Years DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears	3100000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2423256	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	23.02
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1401535	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	20.03
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	33586	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	22.97
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3791205	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.92
CY2022Q1	us-gaap	Profit Loss ProfitLoss	30641000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	11065000	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	223000	USD
CY2022Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	338000	USD
CY2022Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	338000	USD
CY2021Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	157000	USD
CY2021Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	157000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	30303000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	30303000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	10685000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10685000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	279829000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	278827000	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	79000	shares
CY2021Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	141000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	279908000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	278968000	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3061000	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2404000	shares
CY2022Q1	shc	Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability Per Occurrence LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence	10000000	USD
CY2022Q1	us-gaap	Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability	20000000	USD
CY2022Q1	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	2193000	USD
CY2022Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	20452000	USD
CY2022Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	308000	USD
CY2021Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	2644400	USD
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	4472000	USD
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	6179000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	0	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1500000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1300000	USD
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment

Files In Submission

Name	View Source	Status
0001822479-22-000030-index-headers.html	Edgar Link	pending
0001822479-22-000030-index.html	Edgar Link	pending
0001822479-22-000030.txt	Edgar Link	pending
0001822479-22-000030-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
shc-20220331.htm	Edgar Link	pending
shc-20220331.xsd	Edgar Link	pending
shc-20220331_cal.xml	Edgar Link	unprocessable
shc-20220331_def.xml	Edgar Link	unprocessable
shc-20220331_g1.jpg	Edgar Link	pending
shc-20220331_htm.xml	Edgar Link	completed
shc-20220331_lab.xml	Edgar Link	unprocessable
shc-20220331_pre.xml	Edgar Link	unprocessable
shc20220331_exhibitx31x2.htm	Edgar Link	pending
shc20220331_exhibitx32x1.htm	Edgar Link	pending
shc_20220331xexhibitx31x1.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SHC
Sotera Health Co Stock $shc

2022 Q1 Form 10-Q Financial Statement

#000182247922000030 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHC Sotera Health Co Stock $shc

2022 Q1 Form 10-Q Financial Statement

#000182247922000030 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHC
Sotera Health Co Stock $shc